Linda Stein‐Gold
Henry Ford Health System(US)
Publications by Year
Research Areas
Acne and Rosacea Treatments and Effects, Dermatology and Skin Diseases, Skin Protection and Aging, Psoriasis: Treatment and Pathogenesis, Herpesvirus Infections and Treatments
Most-Cited Works
- → A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial(2019)168 cited
- → Why Topical Retinoids Are Mainstay of Therapy for Acne(2017)152 cited
- Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care.(2013)
- → Acne severity grading: Determining essential clinical components and features using a Delphi consensus(2011)66 cited
- Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials.(2018)
- Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents.(2013)
- Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic therapies.(2014)
- Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea.(2014)
- Consensus recommendations from the American acne & rosacea society on the management of rosacea, part 4: a status report on physical modalities and devices.(2014)
- → Importance of treating acne sequelae in skin of color: 6‐month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne‐induced post‐inflammatory hyperpigmentation(2024)17 cited